Genetic effects of the MHC /KIR locus on autoimmune dis
Genetic effects of the MHC /KIR locus on autoimmune dis
批准号:
6951000
负责人:
Mary N. Carrington
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
MHC class I antigen antibody receptor autoimmune disorder cancer risk colorectal neoplasms cytotoxic T lymphocyte disease /disorder proneness /risk family genetics genetic polymorphism histocompatibility typing human genetic material tag human tissue immune response genes immunogenetics inflammatory bowel diseases leukocyte activation /transformation linkage mapping nasopharyngeal neoplasms natural killer cells neoplasm /cancer genetics pathologic process receptor expression rheumatoid arthritis spondylitis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Limited genetic data have been reported regarding effects of HLA on cancer, and no studies have been published that address the influence of the killer immunoglobulin-like receptors (KIR) repertoire on predisposition to cancer. We have established a collaboration with Dr. Metka Ravnik-Glavac in Slovenia to study a large group of individuals with primary colorectal cancer (CRC) and ethnically matched controls. The prevalence of CRC in Slovenia, which has a population size of 2,000,000, is approximately 850 new cases each year. Samples were obtained from clinics throughout the country, so the CRC sample being tested is representative of the entire Slovenian population. We have typed HLA class I and KIR (presence/absence) loci in 484 individuals with colorectal cancer and 212 controls, the latter of which are being supplemented with an additional group of 180 individuals.
Nasopharyngeal carcinoma (NPC), which arises in the epithelial cells of the nasopharynx, exhibits a strong association with Epstein Barr virus (EBV). Although it is a relatively rare malignancy in most populations, it is a substantial source of cancer morbidity in Southern China. NPC occurs among family members of patients and disease risk has been linked with HLA, although the HLA associations differ by ethnic group. We are studying the effects of these genes in a case-control study of NPC involving 618 individuals from Taiwan. These individuals have been typed previously for the HLA-A and HLA-B loci. We have now completed typing HLA-C and the KIR locus in these individuals and the data are now being analysed.
We propose that the presence of activating KIR expressed on natural killer (NK) cells may aggravate autoimmune and inflammatory pathogenesis by inducing NK cell-mediated cytokine secretion and cytolysis. Data supporting this hypothesis was observed in a group of patients with psoriatic arthritis (PsA) attending the University of Toronto Psoriatic Arthritis Clinic in collaboration with Dr. Dafna Gladman. In a related study, we have begun to genotype KIR/HLA in patients with ankylosing spondylitis (AS), a chronic, systemic, inflammatory rheumatic autoimmune disease of the axial skeleton. Although multiple genes are probably involved in susceptibility to AS, HLA-B*27 exhibits the strongest association identified to date, with more than 95% of patients being B*27 positive. The AS samples have been obtained from Addenbrooke's Hospital at Cambridge University, and the Royal National Hospital of Rheumatic Disease, through our collaborators Drs. Rachel Allen and John Trowsdale (Cambridge University). To date, we have received 199 samples from AS patients and are scheduled to receive at minimum 100 additional samples over the next few months. The chronic inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis, are idiopathic, inflammatory disorders of the gastrointestinal tract that are thought to result from inappropriate and ongoing activation of the mucosal immune system. Recently, our collaborators combined linkage results of genome-wide scans from five independent studies using an algorithm called genome search meta-analysis. A locus at 6p, which contains the major histocompatibility complex (MHC), showed the strongest evidence for linkage to disease across the five studies. In collaboration with Dr. John Rioux (Massachusetts Institute of Technology), we have planned a pilot study in which 200 individuals with Crohn's disease and 200 matched (age, gender, geographic location, ancestry) controls, as well as 200 sets of mother-father-IBD affected child trios will be typed for the HLA class I and KIR genes to determine whether previously identified HLA associations with IBD can be attributed in part to KIR genetic variation. If associations are identified, then we will confirm these effects with additional samples from the Genetics Core of the Quebec IBD Genetics Consortium, which is directed by Dr. Rioux. Genetic analysis of HLA/KIR in these diseases may provide information regarding a general
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Killer Inhibitory Receptor Genes in Autoimmune and Infectious Diseases
-
批准号:6433243
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Genetic effects of the MHC and KIR locus on autoimmune d
-
批准号:7291691
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular genetics and population studies of the KIR and HLA gene complexes
-
批准号:8763222
-
项目类别:
-
资助金额:$25.2万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular genetics and population studies of the KIR and HLA gene complexes
-
批准号:9556365
-
项目类别:
-
资助金额:$29.32万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular genetics and population studies of the KIR and HLA gene complexes
-
批准号:8937846
-
项目类别:
-
资助金额:$28.66万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
-
批准号:7733228
-
项目类别:
-
资助金额:$98.31万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
-
批准号:10926068
-
项目类别:
-
资助金额:$63.85万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Genetic Effects on Infectious Disease
-
批准号:6762748
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Role of Killer Immunoglobulin-like Receptor Genes in Aut
-
批准号:6763480
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular genetics and population studies of the KIR and HLA gene complexes
-
批准号:10262153
-
项目类别:
-
资助金额:$49.07万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular genetics and population studies of the KIR and HLA gene complexes
-
批准号:8175344
-
项目类别:
-
资助金额:$50.8万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
CHARACTERIZATION OF VARIATION OF RECOMBINATION IN THE HUMAN MHC
-
批准号:6289331
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Effects of genetic variation on infectious disease
-
批准号:7291805
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
-
批准号:7965675
-
项目类别:
-
资助金额:$118.76万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Genetic effects of the MHC and KIR locus on autoimmune d
-
批准号:7338439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular genetics and population studies of the KIR and HLA gene complexes
-
批准号:8552831
-
项目类别:
-
资助金额:$48.72万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Effects of genetic polymorphism in the MHC, KIR, and related loci on human disea
-
批准号:7592939
-
项目类别:
-
资助金额:$138.36万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
ROLE OF KILLER INHIBITORY RECEPTOR GENES IN AUTOIMMUNE AND INFECTIOUS DISEASES
-
批准号:6289369
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Role of Killer Inhibitory Receptor Genes in Autoimmune a
-
批准号:6559178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
Molecular Genetics of the MHC
-
批准号:7338287
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Mary N. Carrington
-
依托单位:
海外基金